PEAK6 Investments’s Essent Group ESNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,000
Closed -$337K 3644
2024
Q2
$337K Sell
6,000
-2,700
-31% -$150K ﹤0.01% 2463
2024
Q1
$518K Sell
8,700
-16,800
-66% -$912K ﹤0.01% 2425
2023
Q4
$1.34M Buy
25,500
+12,500
+96% +$611K 0.01% 1850
2023
Q3
$615K Sell
13,000
-4,800
-27% -$238K ﹤0.01% 2221
2023
Q2
$833K Buy
17,800
+1,700
+11% +$74K ﹤0.01% 1827
2023
Q1
$645K Buy
16,100
+800
+5% +$32.9K ﹤0.01% 2191
2022
Q4
$595K Buy
15,300
+5,800
+61% +$220K ﹤0.01% 2356
2022
Q3
$331K Sell
9,500
-18,200
-66% -$729K ﹤0.01% 3264
2022
Q2
$1.22M Buy
27,700
+24,100
+669% +$983K ﹤0.01% 2878
2022
Q1
$148K Buy
3,600
+3,500
+3,500% +$156K ﹤0.01% 4072
2021
Q4
$5K Buy
+100
New +$4.58K ﹤0.01% 4960
2021
Q1
Sell
-19,300
Closed -$834K 5014
2020
Q4
$834K Buy
19,300
+5,500
+40% +$238K ﹤0.01% 2654
2020
Q3
$511K Buy
13,800
+3,900
+39% +$139K ﹤0.01% 2837
2020
Q2
$359K Sell
9,900
-3,800
-28% -$117K ﹤0.01% 2957
2020
Q1
$361K Buy
+13,700
New +$608K ﹤0.01% 2359
2019
Q1
Sell
-10,100
Closed -$345K 4027
2018
Q4
$345K Buy
+10,100
New +$386K ﹤0.01% 2622

Other funds holding ESNT

PEAK6 Investments's ESNT Position: Q3 2024 in Review

PEAK6 Investments sold out of Essent Group (ESNT) in Q3 2024, closing a stake of 85 shares — an estimated $4.78K sold.

PEAK6 Investments first reported a position in ESNT in Q4 2018 and held it in 16 quarters. The position peaked at $1.24M in Q1 2021. 317 funds tracked by Wall St. Rank hold ESNT as of Q3 2024.

  • PEAK6 Investments reported no remaining Essent Group position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 85 Essent Group shares in Q3 2024, an estimated $4.78K.
  • PEAK6 Investments first reported a position in Essent Group in Q4 2018 and held it in 16 quarters.
  • PEAK6 Investments's Essent Group position peaked at $1.24M in Q1 2021.
  • 317 funds tracked by Wall St. Rank held Essent Group as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.